Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.
- NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_assertion description "[The utilisation of antitumour T cells induced by cancer vaccination with HER-2 peptides or antibodies (Herceptin) against HER-2, as immunotherapy for oesophageal cancer, is a novel and attractive approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.
- NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_assertion evidence source_evidence_literature NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.
- NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_assertion SIO_000772 15785739 NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.
- NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_assertion wasDerivedFrom befree-2016 NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.
- NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_assertion wasGeneratedBy ECO_0000203 NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.
- befree-2016 importedOn "2016-02-19" NP486842.RAxyOC4Z3CwB4TYdvNlo2lTsmuo7Gq3LQAcPHlZIq-snk130_provenance.